WCM Investment Management
AXSM icon

WCM Investment Management’s Axsome Therapeutics AXSM Stock Holding History

WCM Investment Management’s Portfolio AXSM Stock Details AXSM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$17.3M Sell
107,817
-4,241
-4% -$733K 0.04% 99
2025
Q4 		$16.7M Sell
112,058
-7,638
-6% -$1.07M 0.03% 113
2025
Q3 		$14.1M Buy
119,696
+30
+0% +$3.38K 0.03% 127
2025
Q2 		$12.4M Buy
119,666
+7,718
+7% +$817K 0.03% 136
2025
Q1 		$13.3M Sell
111,948
-48
-0% -$5.47K 0.03% 124
2024
Q4 		$9.5M Sell
111,996
-1,696
-1% -$156K 0.02% 156
2024
Q3 		$10.2M Buy
113,692
+347
+0.3% +$30.3K 0.02% 150
2024
Q2 		$9.08M Buy
113,345
+1,755
+2% +$130K 0.02% 145
2024
Q1 		$8.9M Buy
111,590
+6,782
+6% +$569K 0.02% 144
2023
Q4 		$8.34M Buy
104,808
+8,845
+9% +$591K 0.02% 149
2023
Q3 		$6.71M Buy
95,963
+1,685
+2% +$126K 0.02% 142
2023
Q2 		$6.77M Buy
94,278
+5,733
+6% +$423K 0.02% 147
2023
Q1 		$5.46M Sell
88,545
-194
-0.2% -$12.7K 0.02% 154
2022
Q4 		$6.84M Sell
88,739
-44,966
-34% -$2.69M 0.02% 147
2022
Q3 		$5.9M Buy
133,705
+5,028
+4% +$251K 0.02% 143
2022
Q2 		$4.7M Sell
128,677
-15
-0% -$474 0.02% 150
2022
Q1 		$5.32M Buy
128,692
+8,252
+7% +$256K 0.01% 144
2021
Q4 		$4.55M Buy
120,440
+46,471
+63% +$1.71M 0.01% 154
2021
Q3 		$2.44M Buy
73,969
+371
+0.5% +$14.5K 0.01% 166
2021
Q2 		$4.96M Buy
73,598
+2,934
+4% +$176K 0.01% 139
2021
Q1 		$4M Sell
70,664
-1,443
-2% -$102K 0.01% 143
2020
Q4 		$5.88M Buy
72,107
+197
+0.3% +$14.7K 0.02% 140
2020
Q3 		$5.12M Buy
71,910
+25,905
+56% +$2.02M 0.02% 132
2020
Q2 		$3.79M Buy
46,005
+10,484
+30% +$807K 0.01% 141
2020
Q1 		$2.09M Buy
+35,521
New +$2.89M 0.01% 147

Other funds holding AXSM

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

WCM Investment Management's AXSM Position: Q1 2026 in Review

WCM Investment Management reduced its Axsome Therapeutics (AXSM) stake by 3.8% in Q1 2026, selling an estimated $733K and leaving 107,817 shares worth $17.3M. The position accounts for 0.04% of the portfolio, ranked #99.

WCM Investment Management first reported a position in AXSM in Q1 2020 and has held it in 25 quarters since. 409 funds tracked by Wall St. Rank hold AXSM as of Q1 2026.

  • WCM Investment Management held 107,817 shares of Axsome Therapeutics worth $17.3M as of Q1 2026.
  • WCM Investment Management sold 4,241 Axsome Therapeutics shares in Q1 2026, an estimated $733K.
  • Axsome Therapeutics made up 0.04% of WCM Investment Management's portfolio in Q1 2026, its #99 holding.
  • WCM Investment Management first reported a position in Axsome Therapeutics in Q1 2020 and has held it in 25 quarters since.
  • 409 funds tracked by Wall St. Rank held Axsome Therapeutics as of Q1 2026.

Based on WCM Investment Management's 13F filing for Q1 2026, filed 7 May 2026.